RxDoctor Payments Data

Steven Klein, MD

Family Medicine · Novi, MINPI 1508834227

Payments from drug & device makers

$1,234in general payments, 2019–2025

Across 90 payments — averaging $13.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$195
  • Gilead$166
  • GSK$147
  • AstraZeneca$110
  • Amgen$85
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$59
  • plus $472 from 18 others

What the payments were for

  • Food & beverage$1,234100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,234 in reported general payments places this provider in the 70th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$42,328
Medicare patients
139
Services billed
668

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban33$41,130
XareltoRivaroxaban24$37,479
JardianceEmpagliflozin29$32,866
JanumetSitagliptin Phos/Metformin Hcl28$29,076
OzempicSemaglutide25$27,372
Spiriva RespimatTiotropium Bromide24$26,991
FarxigaDapagliflozin Propanediol24$21,368
Trelegy ElliptaFluticasone/Umeclidin/Vilanter17$16,693
AbrysvoRsv Vacc, Pref A And Pref B/Pf34$10,648
Fluticasone-SalmeterolFluticasone Propion/Salmeterol23$8,767
Atorvastatin Calcium459$5,976
Lantus SolostarInsulin Glargine,hum.Rec.Anlog27$4,855
Metoprolol Succinate208$3,665
ShingrixVaricella-Zoster Ge/As01b/Pf14$2,988
Tamsulosin Hcl134$2,472

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Spiriva Respimat$52$59,85753 claims
PfizerEliquis, Abrysvo$195$51,77867 claims
MerckJanumet$15$29,07628 claims
Novo NordiskOzempic$28$27,37225 claims
AstraZenecaFarxiga$110$21,36824 claims
GSKTrelegy Ellipta, Shingrix$147$19,68131 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,945 family medicine providers in Michigan.

Other family medicine in Novi

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →